Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy

Status unconfirmed · Phase 2

Conditions studied: Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer

In brief

RATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. It is not yet known whether giving monoclonal antibody therapy is more effective than a placebo in treating patients with ovarian epithelial, fallopian tube, or peritoneal cancer who have responded to surgery and chemotherapy. PURPOSE: Randomized phase II trial to study the effectiveness of monoclonal antibody therapy in treating patients with residual disease from stage III or stage IV ovarian epithelial, fallopian tube, or peritoneal cancer following surgery and chemotherapy.

Key facts

Study ID

NCT00003634

Run by

AltaRex

People needed

400

Starts

1998-04-01

Last updated by the study team

2013-11-06

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Alta Bates Comprehensive Cancer Center — Berkeley, California, United States
• USC/Norris Comprehensive Cancer Center — Los Angeles, California, United States
• Jonsson Comprehensive Cancer Center, UCLA — Los Angeles, California, United States
• Chao Family Comprehensive Cancer Center — Orange, California, United States
• Wilshire Oncology Medical Center — Pomona, California, United States
• Stanford University School of Medicine — Stanford, California, United States
• University of Colorado Cancer Center — Denver, Colorado, United States
• Patty Berg Cancer Center — Fort Myers, Florida, United States
• University of Florida Health Science Center - Jacksonville — Jacksonville, Florida, United States
• Walt Disney Memorial Cancer Institute — Orlando, Florida, United States
• University of Chicago Cancer Research Center — Chicago, Illinois, United States
• Saint Mary's Hospital — East Saint Louis, Illinois, United States
• Lutheran General Cancer Care Center — Park Ridge, Illinois, United States
• University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States
• Alton Ochsner Medical Foundation Hospital — New Orleans, Louisiana, United States
• Marlene & Stewart Greenebaum Cancer Center, University of Maryland — Baltimore, Maryland, United States
• New England Medical Center Hospital — Boston, Massachusetts, United States
• Henry Ford Hospital — Detroit, Michigan, United States
• University of Minnesota Medical School — Minneapolis, Minnesota, United States
• Ellis Fischel Cancer Center — Columbia, Missouri, United States
• North Shore University Hospital — Manhasset, New York, United States
• State University of New York - Upstate Medical University — Syracuse, New York, United States
• University of Oklahoma — Oklahoma City, Oklahoma, United States
• Spartanburg Regional Medical Center — Spartanburg, South Carolina, United States
• Baptist Regional Cancer Center - Knoxville — Knoxville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.